Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study

Aims Improved prognosis of patients with chronic systolic heart failure by treatment with beta-blockers has been shown in several randomized controlled multicentre trials. However, in clinical practice only a part of heart failure patients meet the inclusion criteria of these trials. The present stu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal 2005-12, Vol.26 (24), p.2689-2697
Hauptverfasser:	Jost, Andreas, Rauch, Bernhard, Hochadel, Matthias, Winkler, Ralph, Schneider, Steffen, Jacobs, Martina, Kilkowski, Caroline, Kilkowski, Andreas, Lorenz, Herbert, Muth, Kerstin, Zugck, Christian, Remppis, Andrew, Haass, Markus, Senges, Jochen
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Adult Aged Aged, 80 and over Beta-blocker Biological and medical sciences Cardiology. Vascular system Chronic Disease Chronic systolic heart failure Female Heart Heart Failure - drug therapy Heart Failure - mortality Heart failure, cardiogenic pulmonary edema, cardiac enlargement Humans Male Medical sciences MERIT-HF study Middle Aged Prognosis Randomized Controlled Trials as Topic Registries Registry Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!